MedPath

Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption

Phase 4
Conditions
CARBETOCIN FOR PREVENTION OF PLACENTAL RETAINED
Interventions
Registration Number
NCT01827124
Lead Sponsor
Wafaa Uthman Ahmed
Brief Summary

Intravenous Carbetocin is more efficient than intravenous infusion oxytocin in management of placental delivery in 2nd trimester interruption.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
140
Inclusion Criteria
  • Age:16-50 years
  • Pregnancy duration: 14-24weeks
  • Spontaneous abortion or medical induced abortion at 14-24weeks
Exclusion Criteria
  • Age less than 16years and more than 50 years
  • Surgical termination
  • Placenta previa
  • Uterine fibroid

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
carbetocin and placebooxytocin100microgram carbetocin IV and 1cc normal saline(placebo)infusion
carbetocin and placeboCarbetocin100microgram carbetocin IV and 1cc normal saline(placebo)infusion
oxytocin and placeboCarbetocin20Interntional unit oxytocin infusion and 1cc normal saline IV
oxytocin and placebooxytocin20Interntional unit oxytocin infusion and 1cc normal saline IV
Primary Outcome Measures
NameTimeMethod
Record duration of spontaneous placental expulsion after delivery of fetus in second trimester interruptionat the time of delivery
Secondary Outcome Measures
NameTimeMethod
Estimation of blood loss in each group by weighing all pads put under the patient after delivery of fetus tell expulsion of placenta( before and after using of pads).at time of delivery

Trial Locations

Locations (1)

Ain Shams university maternity hospital department of obstetrics and gynacology

🇪🇬

Cairo, Tertiary, Egypt

© Copyright 2025. All Rights Reserved by MedPath